Guang-Hui Liu is a researcher and a fellow of the Chinese Academy of Medical Sciences. He is also a fellow of the International Union of Physiological Sciences and currently serves as the Director of the Academic Committee at the Beijing Institute for Stem Cell and Regenerative Medicine. Dr. Liu has dedicated his career to the field of aging biology. Over the past decade, he has published over 150 research papers in Cell, Nature, Science and other journals. He has also been authorized 33 patents (including 2 PCT patents). Dr. Liu has received the Xplorer Prize, China Youth Science and Technology Award Special Award, Tan Jiazhen Prize in Life Sciences Innovation, Outstanding Scientific and Technological Achievement Award issued by Chinese Academy of Sciences, National Innovation Pioneer Medal, and first prize for the Overseas Chinese Contribution Award. In addition, his representative works were selected as the “Top Ten Advances in Chinese Science" in 2020, the “Top Ten Advances in Life Science in China" in 2018 and 2020, Most Cited Chinese Researchers (ELSEVIER, 2020, 2022). Furthermore, he has been invited to publish reviews and opinions on Cell, Cell Metabolism, Nature Metabolism, Nature Medicine, and Nature Reviews Molecular Cell Biology. Dr. Liu actively engages with the international scientific community, serving as the President of both the Chinese Society of Aging Cell Research (CSACR) and the Aging Biomarker Consortium. Additionally, he holds the roles of Editor-in-Chief at Life Medicine, Deputy Editor-in-Chief at Protein & Cell, and serves on the editorial boards of Cell Reports and Aging Cell.